Position in RNXT
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$255,050
+$42,929 QoQ
Shares Held
252,525
0.0% QoQ
Ownership
0.561%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Wealthspire Advisors, LLC holds $11,039,371 across 15 Biotechnology names. RNXT ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,706 | $6,726,603 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
721,788 | $2,013,788 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
34,359 | $850,728 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
895 | $399,653 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
796,036 | $262,691 | |
| 6 | RNXT |
RenovoRx, Inc.
This page
|
252,525 | $255,050 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,683 | $200,853 | |
| 8 | OLMA |
Olema Pharmaceuticals, Inc.
|
10,172 | $151,664 |
All Filings in RNXT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $255,050 | 252,525 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $212,121 | 252,525 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||